All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention Central Drugs Standard Control Organisation (CDSCO), the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Medical Devices Rules, 2017
All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention Central Drugs Standard Control Organisation (CDSCO), the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window. The average consequence score is 6, matching the 6 beat baseline for this window. Medical Devices Rules, 2017 appears in 1 tracked Healthcare story from July 27, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Medical Devices Rules, 2017. Shared-story counts are live from our verified record — not editorial picks.
India's proposed licensing reform cuts wait times by 25 days for medium-risk and 15 days for high-risk devices, accelerating domestic production and improving healthcare access in a $13 billion market heavily dependent on imports.